Tone mix
Week by week 51 weeks
Share of Vera Therapeutics, Inc. Class A Common Stock's 148 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Aug 17, 2026 · tone -100HC Wainwright Cuts Vera Therapeutics (NASDAQ:VERA) Price Target to $90.00-105
- Week of Jun 1, 2026 · tone +100Vera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgA Nephropathy+85
- Week of Mar 2, 2026 · tone -50Q1 EPS Estimates for Vera Therapeutics Cut by HC Wainwright-82
- Week of Sep 7, 2026 · tone +50Vera Therapeutics (NASDAQ:VERA) Price Target Raised to $83.00+75
- Week of Jun 15, 2026 · tone +100Vera Therapeutics (VERA) Appears Attractive After Latest FDA Agreement+75
- Week of Oct 13, 2025 · tone +99Vera Therapeutics' Lead Kidney Drug Poised For 2026 Launch In Multi-Billion-Dollar Market+66
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Vera Therapeutics, Inc. Class A Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 2 | +100 |
| Last 30 sessions | 7 | +53 |
| Last 90 sessions | 32 | +24 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Monday, October 26, 2026
1 headline, average tone +99: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.rttnews.com · 1 outletWeekly Buzz: AZN, ALVO Score FDA Nod; EYPT Cuts Jobs; RHHBY, GEHC Enter Deal; VERA Posts Trial WinPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Weekly Buzz: AZN, ALVO Score FDA Nod; EYPT Cuts Jobs; RHHBY, GEHC Enter Deal; VERA Posts Trial Win | www.rttnews.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 23, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 2 outletsVera Therapeutics' TRUTAKNA Delivers Strong Phase III IgA Nephropathy ResultsPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Vera Therapeutics' TRUTAKNA Delivers Strong Phase III IgA Nephropathy Results | www.dailypolitical.com | 2 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 20, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletVera Therapeutics to Host ASN Kidney Week Investor Webcast and Third Quarter 2026 Financial Results Conference WebcastNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Vera Therapeutics to Host ASN Kidney Week Investor Webcast and Third Quarter 2026 Financial Results Conference Webcast | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 15, 2026
1 headline, average tone +74: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.rttnews.com · 1 outletCan Vera Therapeutics Stage Another Comeback?Positive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Can Vera Therapeutics Stage Another Comeback? | www.rttnews.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 12, 2026
1 headline, average tone +96: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletVera Therapeutics, Inc. (NASDAQ:VERA) Stock Has Consensus Price Target of $80.15 According to BrokeragesPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Vera Therapeutics, Inc. (NASDAQ:VERA) Stock Has Consensus Price Target of $80.15 According to Brokerages | www.dailypolitical.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Vera Therapeutics, Inc. Class A Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.